Better breast cancer screening should be a universal offering to every woman in the world. Vara’s AI-powered software platform, created with screening radiologists in Germany, mitigates much of the human subjectivity associated with reading mammography results and reduces the repetitive work screening physicians are routinely subjected to. We’re making breast cancer screening more effective, more measurable, and more accessible for everyone, everywhere. By democratising access to early screening around the world, we deliver measurable impact backed by clinical evidence. We are partnering globally, to deliver breast cancer screening where it is needed most. As the first company from Europe’s leading AI venture studio Merantix, Vara has grown since 2018 to become a 30-member international team. Our diverse team consists of highly motivated and ambitious entrepreneurs, healthcare professionals, and technology experts.